GlassScriptPhysician profile
Devang N Patel
NPI 1306952627
$20,551.92
in general payments reported to CMS, 2019-2025
41 companies · $2,317 in 2025
The $2,317 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,809 · 2020: $1,188 · 2021: $2,884 · 2022: $2,386 · 2023: $4,303 · 2024: $4,664 · 2025: $2,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,664 · Travel and Lodging: $2,338 · Long Term Medical Supply Or Device Loan: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,663.90 |
| Travel and Lodging | $2,338.13 |
| Long Term Medical Supply Or Device Loan | $281.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,399.33 | 2021-2025 | Corevalve Evolut R, Intellis Adaptivestim |
| Edwards Lifesciences Corporation | $3,622.37 | 2021-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Abiomed | $2,518.87 | 2019-2025 | Impella |
| Abbott Laboratories | $1,640.21 | 2019-2025 | Portico, Navitor, Xience Skypoint |
| Medtronic Vascular, INC. | $1,136.65 | 2019-2020 | |
| Amgen INC. | $1,034.38 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $866.55 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $751.29 | 2020-2025 | Bodyguardian, General - Therapies, Cds - Mct/Cem Monitoring |
| Novartis Pharmaceuticals Corporation | $454.58 | 2019-2025 | |
| Pfizer INC. | $408.42 | 2019-2024 | |
| Astrazeneca Pharmaceuticals LP | $388.36 | 2019-2025 | Farxiga, Andexxa |
| Inari Medical, INC. | $373.37 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Esperion Therapeutics, INC. | $296.62 | 2020-2025 | Nexletol |
| Novo Nordisk INC | $288.76 | 2024-2025 | Wegovy |
| Biosense Webster, INC. | $265.93 | 2022-2025 | Carto 3 |
Show all 41 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $265.31 | 2020-2023 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $230.26 | 2022-2023 | Verquvo |
| Penumbra, INC. | $157.27 | 2025 | Indigo System |
| Teleflex LLC | $148.23 | 2021 | |
| Biotronik INC. | $143.89 | 2019 | |
| Celonova Biosciences, INC. | $128.25 | 2019 | |
| Shockwave Medical, INC | $123.33 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $100.46 | 2021-2025 | Eliquis |
| Agepha Pharma Fz LLC | $90.24 | 2024 | Lodoco |
| Sanofi-Aventis U.S. LLC | $81.87 | 2019-2024 | |
| Atricure, INC. | $81.73 | 2023 | |
| Ekos Corporation | $64.94 | 2019 | |
| Bardy Diagnostics, INC. | $63.07 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $61.65 | 2019-2023 | Jardiance |
| Thrombolex, INC. | $60.50 | 2025 | Bashir Endovascular Catheter |
| Baxter Healthcare | $51.63 | 2023-2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Altathera Pharmaceuticals LLC | $48.24 | 2022 | |
| Alnylam Pharmaceuticals INC. | $46.42 | 2022-2023 | Onpattro |
| Cardiva Medical, INC. | $41.09 | 2022-2023 | Cardiva Vascade 6/7f Vcs |
| Lantheus Medical Imaging, INC. | $26.03 | 2020 | |
| Siemens Medical Solutions USA, INC. | $19.26 | 2025 | Artis Icono Biplane |
| Cook Medical LLC | $16.50 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.27 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $13.88 | 2021 | |
| Avinger INC. | $13.71 | 2021 | |
| Amarin Pharma, INC. | $13.20 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devang Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.